Dermapharm Holding SE announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was EUR 215.538 million compared to EUR 185.727 million a year ago. Operating income was EUR 60.256 million compared to EUR 25.106 million a year ago. Net income was EUR 39.818 million compared to EUR 11.971 million a year ago. Basic earnings per share from continuing operations was EUR 0.74 compared to EUR 0.22 a year ago. For the half year, sales was EUR 427.750 million compared to EUR 378.196 million a year ago. Operating income was EUR 112.033 million compared to EUR 64.829 million a year ago. Net income was EUR 76.129 million compared to EUR 38.635 million a year ago. Basic earnings per share from continuing operations was EUR 1.41 compared to EUR 0.72 a year ago.